Researchers at the National Institutes of Health (NIH) have started dosing patients in a phase 1 trial of a new influenza vaccine candidate that aims to sidestep the annua
With sales of its COVID-19 vaccines on the wane, Moderna has showcased the projects it will look to for the next phase of its development, headed by new vaccines for influ
NHS England has said it will start offering flu and COVID-19 vaccinations to people from 11th September, as concern rises about a new coronavirus variant that is spreading
Just a few months after suggesting it may not survive to the end of 2023, Novavax has posted improved finances and a second-quarter profit, as it readies the launch of an
Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a
At the upcoming World Without Disease Summit in London, many speakers will focus on specific treatments, therapies, and programmes that exemplify disease screening, prevention, and interception.